WO2016202341A1 - Compounds for use in treating neuromuscular disorders - Google Patents
NMD Pharma to advance neuromuscular disorder therapies with €38m Series A round
Company Presentation
Claus Elsborg Olesen - CBO & Co-Founder @ NMD Pharma - Crunchbase Person Profile
Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn
Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn
Company Presentation
Initiator Pharma
Initiator Pharma
Initiator Pharma | LinkedIn
NMD Pharma - Crunchbase Company Profile & Funding
Well-financed biotech company to enter the clinic in 2020
Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn
NMD Pharma
Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn
Claus Elsborg Olesen - CBO & Co-Founder @ NMD Pharma - Crunchbase Person Profile
Initiator Pharma
PROPOSED DISTRIBUTION OF SANIONA AB'S SHARES IN INITIATOR PHARMA A/S TO SHAREHOLDERS IN SANIONA AB
Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn
PROPOSED DISTRIBUTION OF SANIONA AB'S SHARES IN INITIATOR PHARMA A/S TO SHAREHOLDERS IN SANIONA AB
Claus Elsborg Olesen - Biography
Initiator Pharma
Annual Report 2016 by Lundbeckfonden - issuu
Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn
NMD Pharma company information, funding & investors | Dealroom.co
Claus OLESEN | Aarhus University | AU | Department of Biomedicine
